Hinton proposes FDA-style pre-release safety approval for AI models

Geoffrey Hinton proposed that AI companies must prove their products are safe to regulators before release, comparing the requirement to the FDA's drug approval process. He said such a requirement should apply to AI, noting that drug approval can cost around $1 billion, and warned that AI self-improvement is accelerating.